封面
市場調查報告書
商品編碼
1974952

全球血栓除去裝置市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Thrombectomy Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血栓切除器材市場將從 2025 年的 24.8 億美元成長到 2034 年的 48.7 億美元,2026 年至 2034 年的複合年成長率為 7.79%。

血栓除去裝置。血栓除去裝置用於清除動脈中的血栓,恢復正常血流,因此在中風急救中至關重要。人們對早期中風介入的認知不斷提高,以及醫療基礎設施的改善,都促進了市場成長。

關鍵促進因素包括微創手術技術的進步和多個地區有利的健保報銷政策。醫療機構正在擴大機械取栓術的使用,因為與傳統治療方法相比,它更有效且能帶來更快的復健。人口老化和文明病的增加進一步推高了對先進取栓設備的需求。

未來,技術創新可望提升設備的精準性和安全性。開發中國家醫療保健服務的普及將創造新的成長機會。持續進行的臨床研究和專家培訓計畫將進一步促進設備的普及。隨著卒中管理通訊協定的不斷完善,血栓切除設備市場預計將在全球範圍內實現永續成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球血栓除去裝置市場:依技術分類

  • 市場分析、洞察與預測
  • 機械血栓切除術
  • 抽吸血栓切除手術
  • 再血管血栓切除術

第5章 全球血栓除去裝置市場:按類型分類

  • 市場分析、洞察與預測
  • 自動化設備
  • 手動裝置

第6章 全球血栓除去裝置市場:依應用領域分類

  • 市場分析、洞察與預測
  • 可重複使用設備
  • 免洗設備

第7章 全球血栓除去裝置市場:依應用領域分類

  • 市場分析、洞察與預測
  • 周邊疾病
  • 冠狀動脈疾病
  • 神經系統疾病

第8章 全球血栓除去裝置市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Johnson And Johnson
    • Koninklijke Philips NV
    • Boston Scientific Group
    • Medtronic Plc
    • Terumo Corporation
    • Abbott Laboratories
    • AngioDynamics Inc
    • Penumbra Inc
    • Teleflex Incorporated
    • Stryker Corporation
簡介目錄
Product Code: VMR112110828

The Thrombectomy Devices Market size is expected to reach USD 4.87 Billion in 2034 from USD 2.48 Billion (2025) growing at a CAGR of 7.79% during 2026-2034.

The Global Thrombectomy Devices Market is growing rapidly due to the increasing incidence of stroke and cardiovascular diseases worldwide. Thrombectomy devices are used to remove blood clots from arteries and restore normal blood flow, which is critical in emergency stroke treatment. Rising awareness about early stroke intervention and improved healthcare infrastructure are contributing to market growth.

Major drivers include advancements in minimally invasive surgical technologies and favorable reimbursement policies in several regions. Healthcare providers are increasingly adopting mechanical thrombectomy procedures due to their effectiveness and faster recovery times compared to traditional treatments. The aging population and lifestyle-related health conditions are further increasing the demand for advanced clot removal devices.

In the future, technological innovation is expected to enhance device precision and safety. Expanding healthcare access in developing countries will create new growth opportunities. Ongoing clinical research and training programs for specialists will further support adoption. With continued improvements in stroke management protocols, the thrombectomy devices market is set for sustained expansion globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Mechanical Thrombectomy
  • Aspiration Thrombectomy
  • Rheolytic Thrombectomy

By Type

  • Automated Devices
  • Manual Devices

By Utility

  • Reusable Devices
  • Disposable Devices

By Application

  • Peripheral Diseases
  • Coronary Disease
  • Neural Diseases

COMPANIES PROFILED

  • Johnson and Johnson, Koninklijke Philips NV, Boston Scientific Group, Medtronic plc, Terumo Corporation, Abbott Laboratories, AngioDynamics Inc, Penumbra Inc, Teleflex Incorporated, Stryker Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL THROMBECTOMY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Mechanical Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Aspiration Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Rheolytic Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THROMBECTOMY DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Automated Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Manual Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THROMBECTOMY DEVICES MARKET: BY UTILITY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Utility
  • 6.2. Reusable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Disposable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THROMBECTOMY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Peripheral Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Coronary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Neural Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL THROMBECTOMY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Technology
    • 8.2.2 By Type
    • 8.2.3 By Utility
    • 8.2.4 By Application
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Technology
    • 8.3.2 By Type
    • 8.3.3 By Utility
    • 8.3.4 By Application
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Technology
    • 8.4.2 By Type
    • 8.4.3 By Utility
    • 8.4.4 By Application
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Technology
    • 8.5.2 By Type
    • 8.5.3 By Utility
    • 8.5.4 By Application
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Technology
    • 8.6.2 By Type
    • 8.6.3 By Utility
    • 8.6.4 By Application
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL THROMBECTOMY DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson And Johnson
    • 10.2.2 Koninklijke Philips N.V
    • 10.2.3 Boston Scientific Group
    • 10.2.4 Medtronic Plc
    • 10.2.5 Terumo Corporation
    • 10.2.6 Abbott Laboratories
    • 10.2.7 AngioDynamics Inc
    • 10.2.8 Penumbra Inc
    • 10.2.9 Teleflex Incorporated
    • 10.2.10 Stryker Corporation